Credit Suisse Group started coverage on shares of UnitedHealth Group Incorporated (NYSE:UNH) in a research report released on Thursday. The firm issued an outperform rating and a $233.00 price target on the healthcare conglomerate’s stock.

A number of other analysts have also recently commented on UNH. Cowen and Company reaffirmed an outperform rating and set a $220.00 target price (up from $175.00) on shares of UnitedHealth Group in a report on Friday, August 11th. Oppenheimer Holdings, Inc. upped their target price on shares of UnitedHealth Group from $215.00 to $205.00 and gave the company an outperform rating in a report on Wednesday, October 18th. Zacks Investment Research cut shares of UnitedHealth Group from a buy rating to a hold rating in a report on Tuesday, September 26th. Mizuho reaffirmed a buy rating on shares of UnitedHealth Group in a report on Tuesday, October 24th. Finally, Morgan Stanley upped their target price on shares of UnitedHealth Group from $210.00 to $215.00 and gave the company an overweight rating in a report on Thursday, August 17th. Three investment analysts have rated the stock with a hold rating and twenty-four have assigned a buy rating to the company’s stock. The company has an average rating of Buy and an average target price of $216.65.

UnitedHealth Group (NYSE UNH) opened at $212.87 on Thursday. The firm has a market cap of $205,815.47, a P/E ratio of 22.17, a P/E/G ratio of 1.58 and a beta of 0.64. UnitedHealth Group has a 52-week low of $136.22 and a 52-week high of $213.83. The company has a current ratio of 0.70, a quick ratio of 0.72 and a debt-to-equity ratio of 0.52.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.57 by $0.09. The company had revenue of $50.32 billion for the quarter, compared to the consensus estimate of $50.38 billion. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The firm’s revenue for the quarter was up 8.7% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $2.17 earnings per share. equities analysts expect that UnitedHealth Group will post 9.99 EPS for the current year.

WARNING: This story was reported by Watch List News and is owned by of Watch List News. If you are reading this story on another website, it was copied illegally and reposted in violation of US and international copyright & trademark legislation. The original version of this story can be accessed at https://www.watchlistnews.com/unitedhealth-group-incorporated-unh-research-coverage-started-at-credit-suisse-group/1682425.html.

In other UnitedHealth Group news, Director Richard T. Burke sold 15,000 shares of the stock in a transaction on Monday, August 21st. The shares were sold at an average price of $191.71, for a total transaction of $2,875,650.00. Following the completion of the transaction, the director now owns 1,818,898 shares in the company, valued at $348,700,935.58. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Larry C. Renfro sold 50,574 shares of the stock in a transaction on Friday, September 15th. The shares were sold at an average price of $198.11, for a total transaction of $10,019,215.14. Following the transaction, the insider now owns 195,625 shares of the company’s stock, valued at approximately $38,755,268.75. The disclosure for this sale can be found here. Insiders have sold 72,149 shares of company stock valued at $14,212,342 in the last quarter. 0.89% of the stock is owned by company insiders.

A number of hedge funds have recently added to or reduced their stakes in UNH. Jennison Associates LLC lifted its position in UnitedHealth Group by 146.0% during the third quarter. Jennison Associates LLC now owns 5,541,977 shares of the healthcare conglomerate’s stock valued at $1,085,396,000 after purchasing an additional 3,289,470 shares during the last quarter. Harbour Capital Advisors LLC lifted its position in UnitedHealth Group by 18,383.4% during the second quarter. Harbour Capital Advisors LLC now owns 2,516,706 shares of the healthcare conglomerate’s stock valued at $13,573,000 after purchasing an additional 2,503,090 shares during the last quarter. Janus Henderson Group PLC lifted its position in UnitedHealth Group by 1,820.1% during the second quarter. Janus Henderson Group PLC now owns 2,388,641 shares of the healthcare conglomerate’s stock valued at $442,896,000 after purchasing an additional 2,264,242 shares during the last quarter. Vanguard Group Inc. lifted its position in UnitedHealth Group by 2.5% during the second quarter. Vanguard Group Inc. now owns 64,578,618 shares of the healthcare conglomerate’s stock valued at $11,974,168,000 after purchasing an additional 1,588,516 shares during the last quarter. Finally, Parametric Portfolio Associates LLC lifted its position in UnitedHealth Group by 77.3% during the second quarter. Parametric Portfolio Associates LLC now owns 3,584,134 shares of the healthcare conglomerate’s stock valued at $664,570,000 after purchasing an additional 1,562,661 shares during the last quarter. Institutional investors and hedge funds own 86.17% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.